John Bradley

17.5k citations
246 papers · 9.3k · 8 hit papers · h-index 41

Impact in

  • Rheumatology top 0.1%
    • Rheumatoid Arthritis Research and Therapies
    • Systemic Lupus Erythematosus Research
    • Osteoarthritis Treatment and Mechanisms
  • Hematology top 0.5%
    • Autoimmune and Inflammatory Disorders Research

Papers in

John Bradley

235 papers receiving 8.9k citations

John Bradley's Hit Papers

Tofacitinib versus Methotrexate in Rheumatoid Arthritis 2014 · 598 citations
5980+12+24Years since publication250500750

Peers

John Bradley
Comparison fields: 5 of 191
  • Rheumatology 4.1k
  • Hematology 1.7k
  • Genetics 1.1k
  • Immunology 1.2k
  • Public Health, Environmental and Occupational Health 1.6k
Replace Peter C. Taylor with:
Peter C. Taylor United Kingdom
Maikel P. Peppelenbosch Netherlands
Nancy A. Shadick United States
David A. Fox United States
Louis Dubertret France
Gordon W. Duff United Kingdom
Juan‐Manuel Anaya Colombia
Tsutomu Chiba Japan
Josef S Smolen Austria
Jerome I. Rotter United States
John Bradley relative to Peter C. Taylor United Kingdom Peter C. Taylor's profile →
Citations per field
00.5×1.5×2.5×
Peter C. Taylor · 1×
Citations per year

Countries citing papers authored by John Bradley

Since Specialization
Citations

This map shows the geographic impact of John Bradley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Bradley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Bradley more than expected).

Fields of papers citing papers by John Bradley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Bradley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Bradley. The network helps show where John Bradley may publish in the future.

Co-authors

The 25 scholars most cited alongside John Bradley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John Bradley Line = papers co-authored together John Bradley links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 246 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
Hit paper breakdown →
2012790
2
Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis
Hit paper breakdown →
2012739
3
Tofacitinib versus Methotrexate in Rheumatoid Arthritis
Hit paper breakdown →
2014598
4
Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial
Hit paper breakdown →
2013548
5
In vivo alteration of telomere sequences and senescence caused by mutated Tetrahymena telomerase RNAs
Hit paper breakdown →
1990539
6
Comparison of an Antiinflammatory Dose of Ibuprofen, an Analgesic Dose of Ibuprofen, and Acetaminophen in the Treatment of Patients with Osteoarthritis of the Knee
Hit paper breakdown →
1991472
7
Tofacitinib (CP‐690,550) in patients with rheumatoid arthritis receiving methotrexate: Twelve‐month data from a twenty‐four–month phase III randomized radiographic study
Hit paper breakdown →
2013456
8
Tofacitinib in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis
Hit paper breakdown →
2013366
9 1999328
10 2014219
11 2005200
12 2008178
13 2010171
14 2020164
15 2013110
16
A randomized, double-blinded, placebo-controlled clinical trial of LY333013, a selective inhibitor of group II secretory phospholipase A2, in the treatment of rheumatoid arthritis.
200592
17 201685
18 201379
19 201679
20 200278

About John Bradley

John Bradley is a scholar working on Public Health, Environmental and Occupational Health, Rheumatology, Genetics, Plant Science and Ecology, Evolution, Behavior and Systematics, having authored 246 papers that have together received 9.3k indexed citations. Recurring topics across this work include Malaria Research and Control (74 papers), Mosquito-borne diseases and control (71 papers), Rheumatoid Arthritis Research and Therapies (42 papers), Lepidoptera: Biology and Taxonomy (33 papers), Insect Pest Control Strategies (21 papers), Autoimmune and Inflammatory Disorders Research (19 papers), Systemic Lupus Erythematosus Research (17 papers) and Parasites and Host Interactions (16 papers). The work is most often cited by research in Rheumatology (4.1k citations), Hematology (1.7k citations), Genetics (1.1k citations), Immunology (1.2k citations) and Public Health, Environmental and Occupational Health (1.6k citations). John Bradley has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Samuel H. Zwillich, Gene V. Wallenstein, David Gruben, Roy Fleischmann, Sriram Krishnaswami, Tamás Koncz, Barry P. Katz, Kenneth D. Brandt, Laura D. Attardi and Elizabeth H. Blackburn. Their work appears in journals such as Malaria Journal, Annals of the Rheumatic Diseases, Bulletin of Entomological Research, Parasites & Vectors and Trials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact